| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.875 | 0.004 | 0.875 | Platelet antagonist | 0.762 0.004 CID_154699905 0.814 0.004 CID_154699867 | ||
| 0.848 | 0.003 | 0.848 | Vasodilator, peripheral | 0.832 0.003 CID_154699905 0.757 0.004 CID_154699867 | ||
| 0.84 | 0.01 | 0.904 | Antiinflammatory | 0.904 0.005 CID_154699905 0.897 0.005 CID_154699867 | CID_154699905 | |
| 0.812 | 0.009 | 0.88 | Caspase 9 stimulant | 0.88 0.004 CID_154699905 0.838 0.006 CID_154699867 | CID_154699905 | |
| 0.805 | 0.004 | 0.933 | Antithrombotic | 0.932 0.002 CID_154699905 0.933 0.002 CID_154699867 | CID_154699867 | |
| 0.768 | 0.004 | 0.768 | Hypolipemic | 0.657 0.005 CID_154699905 0.543 0.009 CID_154699867 | ||
| 0.758 | 0.005 | 0.876 | Cholesterol antagonist | 0.876 0.003 CID_154699905 0.874 0.003 CID_154699867 | CID_154699905 | |
| 0.688 | 0.005 | 0.71 | Apoptosis antagonist | 0.671 0.005 CID_154699905 0.71 0.004 CID_154699867 | CID_154699867 | |
| 0.658 | 0.005 | 0.658 | Vasodilator | 0.65 0.005 CID_154699905 0.592 0.006 CID_154699867 | ||
| 0.651 | 0.005 | 0.651 | Platelet aggregation inhibitor | 0.27 0.044 CID_154699905 0.249 0.052 CID_154699867 | ||
| 0.644 | 0.003 | 0.644 | Phospholipase C inhibitor | 0.568 0.004 CID_154699905 0.553 0.005 CID_154699867 | ||
| 0.631 | 0.003 | 0.631 | Aldehyde dehydrogenase inhibitor | 0.37 0.007 CID_154699905 0.479 0.005 CID_154699867 | ||
| 0.623 | 0.004 | 0.852 | Non-steroidal antiinflammatory agent | 0.852 0.003 CID_154699905 0.639 0.004 CID_154699867 | CID_154699905 | |
| 0.632 | 0.022 | 0.788 | Cyclophilin D inhibitor | 0.774 0.008 CID_154699905 0.788 0.007 CID_154699867 | CID_154699867 | |
| 0.629 | 0.043 | 0.818 | Apoptosis agonist | 0.818 0.015 CID_154699905 0.744 0.024 CID_154699867 | CID_154699905 | |
| 0.592 | 0.012 | 0.692 | Immunomodulator | 0.692 0.005 CID_154699905 0.682 0.006 CID_154699867 | CID_154699905 | |
| 0.574 | 0.013 | 0.634 | Histamine release inhibitor | 0.587 0.011 CID_154699905 0.634 0.008 CID_154699867 | CID_154699867 | |
| 0.576 | 0.016 | 0.64 | Immunosuppressant | 0.64 0.009 CID_154699905 0.625 0.01 CID_154699867 | CID_154699905 | |
| 0.54 | 0.003 | 0.54 | Succinate dehydrogenase inhibitor | 0.185 0.062 CID_154699905 0.223 0.034 CID_154699867 | ||
| 0.555 | 0.022 | 0.765 | Immunostimulant | 0.765 0.005 CID_154699905 0.756 0.005 CID_154699867 | CID_154699905 | |
| 0.523 | 0.005 | 0.578 | Platelet adhesion inhibitor | 0.578 0.004 CID_154699905 0.55 0.004 CID_154699867 | CID_154699905 | |
| 0.517 | 0.003 | 0.517 | Prostaglandin EP2 antagonist | 0.285 0.004 CID_154699905 0.226 0.005 CID_154699867 | ||
| 0.514 | 0.006 | 0.584 | Interleukin 2 agonist | 0.566 0.004 CID_154699905 0.584 0.004 CID_154699867 | CID_154699867 | |
| 0.506 | 0.005 | 0.552 | Alpha-N-acetylglucosaminidase inhibitor | 0.552 0.004 CID_154699905 0.551 0.004 CID_154699867 | CID_154699905 | |
| 0.498 | 0.003 | 0.498 | Vanilloid agonist | 0.296 0.005 CID_154699905 0.225 0.005 CID_154699867 | ||
| 0.534 | 0.04 | 0.87 | Transcription factor NF kappa B inhibitor | 0.87 0.008 CID_154699905 0.799 0.013 CID_154699867 | CID_154699905 | |
| 0.489 | 0.003 | 0.489 | Electron transport complex I inhibitor | 0.177 0.011 CID_154699905 0.149 0.021 CID_154699867 | ||
| 0.503 | 0.018 | 0.503 | Lipoxygenase inhibitor | |||
| 0.519 | 0.035 | 0.741 | Antibacterial | 0.741 0.006 CID_154699905 0.704 0.008 CID_154699867 | CID_154699905 | |
| 0.488 | 0.004 | 0.545 | Protein kinase stimulant | 0.545 0.003 CID_154699905 0.518 0.004 CID_154699867 | CID_154699905 | |
| 0.484 | 0.002 | 0.484 | Prostaglandin F2 alpha antagonist | 0.219 0.004 CID_154699905 0.159 0.004 CID_154699867 | ||
| 0.485 | 0.005 | 0.485 | Insulin secretagoues | 0.416 0.006 CID_154699905 0.408 0.006 CID_154699867 | ||
| 0.495 | 0.021 | 0.737 | Antioxidant | 0.737 0.005 CID_154699905 0.695 0.006 CID_154699867 | CID_154699905 | |
| 0.477 | 0.004 | 0.681 | Expectorant | 0.681 0.002 CID_154699905 0.6 0.003 CID_154699867 | CID_154699905 | |
| 0.476 | 0.004 | 0.476 | Phospholipase A2 inhibitor | 0.399 0.005 CID_154699905 0.456 0.004 CID_154699867 | ||
| 0.485 | 0.025 | 0.579 | Spasmolytic | 0.579 0.015 CID_154699905 0.406 0.039 CID_154699867 | CID_154699905 | |
| 0.47 | 0.011 | 0.604 | Interleukin agonist | 0.602 0.005 CID_154699905 0.604 0.005 CID_154699867 | CID_154699867 | |
| 0.46 | 0.002 | 0.46 | Leukotriene antagonist | 0.325 0.003 CID_154699905 0.261 0.004 CID_154699867 | ||
| 0.471 | 0.014 | 0.836 | Angiogenesis stimulant | 0.819 0.004 CID_154699905 0.836 0.003 CID_154699867 | CID_154699867 | |
| 0.441 | 0.004 | 0.441 | Gastrin inhibitor | 0.353 0.01 CID_154699905 0.355 0.009 CID_154699867 | ||
| 0.43 | 0.002 | 0.43 | Leukotriene B4 antagonist | 0.325 0.003 CID_154699905 0.309 0.003 CID_154699867 | ||
| 0.43 | 0.003 | 0.43 | Adenylate kinase inhibitor | 0.303 0.007 CID_154699905 0.34 0.005 CID_154699867 | ||
| 0.46 | 0.038 | 0.46 | Aldehyde oxidase inhibitor | |||
| 0.435 | 0.022 | 0.67 | Hypoglycemic | 0.626 0.007 CID_154699905 0.67 0.005 CID_154699867 | CID_154699867 | |
| 0.415 | 0.005 | 0.415 | Insulin sensitizer | 0.282 0.02 CID_154699905 0.281 0.021 CID_154699867 | ||
| 0.412 | 0.005 | 0.412 | GABA C receptor agonist | 0.099 0.068 CID_154699867 | ||
| 0.408 | 0.001 | 0.408 | Prostaglandin agonist | 0.19 0.003 CID_154699905 0.122 0.004 CID_154699867 | ||
| 0.43 | 0.027 | 0.43 | Interleukin antagonist | 0.208 0.08 CID_154699905 0.171 0.103 CID_154699867 | ||
| 0.447 | 0.044 | 0.447 | Toll-Like receptor agonist | 0.218 0.181 CID_154699867 | ||
| 0.41 | 0.01 | 0.528 | Interferon gamma antagonist | 0.528 0.005 CID_154699905 0.523 0.005 CID_154699867 | CID_154699905 | |
| 0.387 | 0.002 | 0.387 | Prostaglandin E2 agonist | 0.104 0.004 CID_154699905 0.063 0.005 CID_154699867 | ||
| 0.388 | 0.003 | 0.388 | Mucolytic | 0.331 0.004 CID_154699905 0.27 0.005 CID_154699867 | ||
| 0.388 | 0.005 | 0.464 | Cell adhesion inhibitor | 0.431 0.005 CID_154699905 0.464 0.005 CID_154699867 | CID_154699867 | |
| 0.399 | 0.017 | 0.399 | Sodium/bile acid cotransporter inhibitor | 0.278 0.1 CID_154699905 0.322 0.06 CID_154699867 | ||
| 0.382 | 0.004 | 0.382 | Prostaglandin antagonist | |||
| 0.419 | 0.042 | 0.419 | 5 Hydroxytryptamine release stimulant | 0.279 0.077 CID_154699905 0.204 0.118 CID_154699867 | ||
| 0.384 | 0.013 | 0.524 | Melanin inhibitor | 0.524 0.006 CID_154699905 0.481 0.008 CID_154699867 | CID_154699905 | |
| 0.377 | 0.011 | 0.377 | Bone formation stimulant | 0.269 0.021 CID_154699905 0.2 0.036 CID_154699867 | ||
| 0.368 | 0.009 | 0.61 | Alkylator | 0.61 0.004 CID_154699905 0.473 0.005 CID_154699867 | CID_154699905 | |
| 0.359 | 0.005 | 0.359 | Neurotrophic factor | 0.243 0.013 CID_154699905 0.234 0.015 CID_154699867 | ||
| 0.396 | 0.046 | 0.429 | Caspase 3 stimulant | 0.429 0.036 CID_154699905 0.428 0.036 CID_154699867 | CID_154699905 | |
| 0.37 | 0.02 | 0.37 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.352 | 0.004 | 0.352 | Vanilloid 1 agonist | 0.312 0.004 CID_154699905 0.29 0.004 CID_154699867 | ||
| 0.37 | 0.026 | 0.529 | DNA synthesis inhibitor | 0.482 0.015 CID_154699905 0.529 0.011 CID_154699867 | CID_154699867 | |
| 0.342 | 0.004 | 0.342 | TRPA1 agonist | 0.153 0.029 CID_154699905 0.165 0.022 CID_154699867 | ||
| 0.409 | 0.073 | 0.409 | 5 Hydroxytryptamine release inhibitor | 0.359 0.108 CID_154699905 0.334 0.129 CID_154699867 | ||
| 0.339 | 0.004 | 0.434 | Phosphofructokinase-1 inhibitor | 0.377 0.004 CID_154699905 0.434 0.003 CID_154699867 | CID_154699867 | |
| 0.39 | 0.064 | 0.39 | Toll-Like receptor 7 agonist | |||
| 0.354 | 0.031 | 0.633 | Nitric oxide antagonist | 0.586 0.01 CID_154699905 0.633 0.008 CID_154699867 | CID_154699867 | |
| 0.321 | 0.002 | 0.321 | Adenylate cyclase stimulant | 0.247 0.004 CID_154699905 0.224 0.006 CID_154699867 | ||
| 0.327 | 0.009 | 0.469 | Cell wall synthesis inhibitor | 0.469 0.004 CID_154699905 0.446 0.005 CID_154699867 | CID_154699905 | |
| 0.328 | 0.012 | 0.328 | Interleukin 6 antagonist | 0.3 0.015 CID_154699905 0.256 0.022 CID_154699867 | ||
| 0.319 | 0.004 | 0.319 | Toll-Like receptor 2 antagonist | 0.18 0.034 CID_154699905 0.203 0.022 CID_154699867 | ||
| 0.32 | 0.005 | 0.32 | Glutamate dehydrogenase inhibitor | 0.113 0.025 CID_154699905 0.144 0.017 CID_154699867 | ||
| 0.315 | 0.004 | 0.389 | Triose-phosphate isomerase inhibitor | 0.323 0.004 CID_154699905 0.389 0.004 CID_154699867 | CID_154699867 | |
| 0.319 | 0.009 | 0.319 | 5-Lipoxygenase inhibitor | |||
| 0.314 | 0.005 | 0.314 | Catalase inhibitor | 0.063 0.061 CID_154699867 | ||
| 0.334 | 0.026 | 0.334 | Growth hormone agonist | 0.133 0.103 CID_154699867 | ||
| 0.329 | 0.023 | 0.596 | Hepatoprotectant | 0.564 0.005 CID_154699905 0.596 0.005 CID_154699867 | CID_154699867 | |
| 0.311 | 0.005 | 0.383 | Cell adhesion molecule inhibitor | 0.316 0.005 CID_154699905 0.383 0.005 CID_154699867 | CID_154699867 | |
| 0.324 | 0.019 | 0.362 | DNA methyltransferase I inhibitor | 0.362 0.012 CID_154699905 0.359 0.013 CID_154699867 | CID_154699905 | |
| 0.342 | 0.04 | 0.578 | Tumour necrosis factor alpha release inhibitor | 0.578 0.008 CID_154699905 0.561 0.009 CID_154699867 | CID_154699905 | |
| 0.307 | 0.007 | 0.307 | Ferrochelatase inhibitor | |||
| 0.301 | 0.002 | 0.301 | Prostaglandin D2 agonist | 0.08 0.004 CID_154699905 0.071 0.004 CID_154699867 | ||
| 0.307 | 0.011 | 0.307 | Cholesterol synthesis inhibitor | 0.218 0.023 CID_154699905 0.17 0.036 CID_154699867 | ||
| 0.318 | 0.021 | 0.387 | Thrombolytic | 0.387 0.012 CID_154699905 0.385 0.013 CID_154699867 | CID_154699905 | |
| 0.298 | 0.006 | 0.429 | ATPase inhibitor | 0.429 0.003 CID_154699905 0.42 0.003 CID_154699867 | CID_154699905 | |
| 0.315 | 0.027 | 0.315 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.289 | 0.002 | 0.289 | Aconitate hydratase inhibitor | 0.055 0.031 CID_154699867 | ||
| 0.289 | 0.003 | 0.289 | Prolactin inhibitor | |||
| 0.297 | 0.011 | 0.305 | DNA polymerase I inhibitor | 0.276 0.013 CID_154699905 0.305 0.011 CID_154699867 | CID_154699867 | |
| 0.289 | 0.005 | 0.289 | Peroxisome proliferator-activated receptor gamma agonist | 0.1 0.028 CID_154699905 0.127 0.018 CID_154699867 | ||
| 0.317 | 0.034 | 0.317 | Peroxidase inhibitor | |||
| 0.283 | 0.003 | 0.283 | Prostaglandin EP4 antagonist | |||
| 0.295 | 0.015 | 0.295 | Antipruritic | 0.181 0.063 CID_154699905 0.129 0.125 CID_154699867 | ||
| 0.286 | 0.008 | 0.481 | Mediator release inhibitor | 0.362 0.005 CID_154699905 0.481 0.004 CID_154699867 | CID_154699867 | |
| 0.273 | 0.004 | 0.273 | Sphingomyelinase inhibitor | 0.258 0.004 CID_154699905 0.262 0.004 CID_154699867 | ||
| 0.271 | 0.003 | 0.271 | Leukotriene B4 receptor 1 antagonist | 0.066 0.005 CID_154699905 0.063 0.005 CID_154699867 | ||
| 0.269 | 0.003 | 0.269 | Thromboxane synthase inhibitor | 0.053 0.041 CID_154699905 0.056 0.035 CID_154699867 | ||
| 0.27 | 0.004 | 0.27 | Folate antagonist | 0.176 0.015 CID_154699905 0.182 0.013 CID_154699867 | ||
| 0.276 | 0.01 | 0.278 | Interleukin 4 antagonist | 0.278 0.01 CID_154699905 0.258 0.012 CID_154699867 | CID_154699905 | |
| 0.299 | 0.033 | 0.329 | Anesthetic general | 0.32 0.029 CID_154699905 0.329 0.027 CID_154699867 | CID_154699867 | |
| 0.266 | 0.002 | 0.266 | Acyl-CoA dehydrogenase inhibitor | 0.185 0.006 CID_154699905 0.18 0.007 CID_154699867 | ||
| 0.266 | 0.003 | 0.266 | Fumarate hydratase inhibitor | 0.055 0.012 CID_154699905 0.073 0.008 CID_154699867 | ||
| 0.293 | 0.03 | 0.39 | DNA methylase inhibitor | 0.39 0.012 CID_154699905 0.389 0.012 CID_154699867 | CID_154699905 | |
| 0.265 | 0.005 | 0.265 | Gastric antisecretory | 0.11 0.053 CID_154699905 | ||
| 0.261 | 0.003 | 0.261 | Thromboxane antagonist | 0.075 0.023 CID_154699905 0.076 0.022 CID_154699867 | ||
| 0.261 | 0.004 | 0.261 | Arachidonic acid antagonist | 0.223 0.015 CID_154699905 0.224 0.015 CID_154699867 | ||
| 0.279 | 0.023 | 0.279 | Protein-tyrosine phosphatase inhibitor | 0.21 0.043 CID_154699905 0.237 0.034 CID_154699867 | ||
| 0.26 | 0.006 | 0.284 | Microtubule formation inhibitor | 0.284 0.003 CID_154699905 0.264 0.005 CID_154699867 | CID_154699905 | |
| 0.258 | 0.004 | 0.258 | Glutamate decarboxylase inhibitor | |||
| 0.258 | 0.004 | 0.258 | Leukotriene synthesis inhibitor | 0.108 0.022 CID_154699905 0.104 0.024 CID_154699867 | ||
| 0.287 | 0.034 | 0.287 | RNA-directed DNA polymerase inhibitor | 0.237 0.058 CID_154699905 0.244 0.053 CID_154699867 | ||
| 0.321 | 0.072 | 0.496 | Vasodilator, coronary | 0.496 0.016 CID_154699905 0.456 0.022 CID_154699867 | CID_154699905 | |
| 0.25 | 0.002 | 0.25 | Prostacyclin agonist | 0.078 0.004 CID_154699905 0.05 0.004 CID_154699867 | ||
| 0.255 | 0.009 | 0.255 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.193 0.017 CID_154699905 0.249 0.01 CID_154699867 | ||
| 0.248 | 0.004 | 0.248 | Prostaglandin EP3 antagonist | 0.032 0.019 CID_154699905 | ||
| 0.251 | 0.008 | 0.468 | Selectin antagonist | 0.448 0.003 CID_154699905 0.468 0.003 CID_154699867 | CID_154699867 | |
| 0.259 | 0.021 | 0.499 | Hemostatic | 0.499 0.004 CID_154699905 0.496 0.004 CID_154699867 | CID_154699905 | |
| 0.237 | 0.003 | 0.237 | Thromboxane A2 antagonist | 0.071 0.02 CID_154699905 0.072 0.02 CID_154699867 | ||
| 0.258 | 0.025 | 0.437 | Lipid peroxidase inhibitor | 0.437 0.008 CID_154699905 0.362 0.012 CID_154699867 | CID_154699905 | |
| 0.238 | 0.006 | 0.238 | Carbamoyl phosphate synthetase inhibitor | 0.076 0.031 CID_154699905 0.097 0.022 CID_154699867 | ||
| 0.263 | 0.032 | 0.269 | Neurotrophic factor enhancer | 0.235 0.048 CID_154699905 0.269 0.029 CID_154699867 | CID_154699867 | |
| 0.233 | 0.005 | 0.233 | Alcohol oxidase inhibitor | |||
| 0.229 | 0.002 | 0.229 | Prostaglandin EP2 agonist | 0.119 0.003 CID_154699905 0.085 0.003 CID_154699867 | ||
| 0.233 | 0.007 | 0.233 | Hematopoietic | |||
| 0.242 | 0.018 | 0.242 | Protein-tyrosine phosphatase 1B inhibitor | 0.213 0.026 CID_154699905 0.226 0.022 CID_154699867 | ||
| 0.247 | 0.024 | 0.634 | Monophenol monooxygenase inhibitor | 0.634 0.005 CID_154699905 0.627 0.005 CID_154699867 | CID_154699905 | |
| 0.224 | 0.005 | 0.293 | Interferon agonist | 0.293 0.003 CID_154699905 0.259 0.004 CID_154699867 | CID_154699905 | |
| 0.221 | 0.006 | 0.221 | Toll-Like receptor 2 agonist | 0.194 0.008 CID_154699905 0.216 0.006 CID_154699867 | ||
| 0.214 | 0.004 | 0.214 | Ornithine decarboxylase inhibitor | 0.115 0.029 CID_154699905 0.128 0.02 CID_154699867 | ||
| 0.269 | 0.061 | 0.587 | Free radical scavenger | 0.583 0.009 CID_154699905 0.587 0.009 CID_154699867 | CID_154699867 | |
| 0.314 | 0.107 | 0.314 | GABA C receptor rho-3 antagonist | |||
| 0.209 | 0.003 | 0.209 | Lysophosphatidic acid 2 receptor antagonist | |||
| 0.208 | 0.004 | 0.208 | Prostacyclin antagonist | 0.029 0.027 CID_154699905 | ||
| 0.208 | 0.008 | 0.208 | Keratolytic | |||
| 0.238 | 0.038 | 0.238 | Lipocortins synthesis antagonist | 0.147 0.109 CID_154699905 0.188 0.065 CID_154699867 | ||
| 0.21 | 0.01 | 0.21 | Sphingosine 1-phosphate receptor 2 agonist | |||
| 0.24 | 0.044 | 0.251 | P-glycoprotein inhibitor | 0.251 0.041 CID_154699905 0.162 0.1 CID_154699867 | CID_154699905 | |
| 0.199 | 0.004 | 0.199 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.197 | 0.004 | 0.217 | Ca2+-transporting ATPase inhibitor | 0.217 0.003 CID_154699905 0.193 0.004 CID_154699867 | CID_154699905 | |
| 0.196 | 0.005 | 0.196 | Prostaglandin E2 antagonist | |||
| 0.199 | 0.008 | 0.199 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.192 | 0.001 | 0.192 | Prostaglandin EP4 agonist | 0.113 0.003 CID_154699905 0.076 0.004 CID_154699867 | ||
| 0.197 | 0.007 | 0.243 | Toll-Like receptor 4 antagonist | 0.234 0.004 CID_154699905 0.243 0.004 CID_154699867 | CID_154699867 | |
| 0.202 | 0.014 | 0.202 | Potassium channel (Ca-activated) activator | 0.111 0.047 CID_154699905 | ||
| 0.212 | 0.024 | 0.212 | Catenin beta inhibitor | |||
| 0.223 | 0.037 | 0.489 | Amylase inhibitor | 0.4 0.009 CID_154699905 0.489 0.006 CID_154699867 | CID_154699867 | |
| 0.186 | 0.002 | 0.211 | Glucose-6-phosphate isomerase inhibitor | 0.182 0.002 CID_154699905 0.211 0.001 CID_154699867 | CID_154699867 | |
| 0.196 | 0.013 | 0.196 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.185 | 0.004 | 0.185 | Oleamide hydrolase inhibitor | |||
| 0.264 | 0.084 | 0.264 | Insulysin inhibitor | |||
| 0.199 | 0.021 | 0.199 | Aminopeptidase B inhibitor | |||
| 0.195 | 0.022 | 0.345 | Antineoplastic antibiotic | 0.345 0.007 CID_154699905 0.342 0.007 CID_154699867 | CID_154699905 | |
| 0.175 | 0.002 | 0.175 | Lysophosphatidic acid 3 receptor antagonist | 0.056 0.027 CID_154699905 0.062 0.021 CID_154699867 | ||
| 0.169 | 0.002 | 0.169 | Vanilloid 4 agonist | 0.093 0.023 CID_154699905 0.074 0.054 CID_154699867 | ||
| 0.183 | 0.017 | 0.183 | GABA C receptor antagonist | |||
| 0.18 | 0.014 | 0.18 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.173 | 0.009 | 0.173 | Anabolic | 0.14 0.024 CID_154699905 0.128 0.033 CID_154699867 | ||
| 0.171 | 0.009 | 0.171 | Potassium channel large-conductance Ca-activated activator | 0.107 0.021 CID_154699905 0.07 0.044 CID_154699867 | ||
| 0.172 | 0.01 | 0.172 | CDC25A inhibitor | 0.074 0.051 CID_154699905 0.093 0.032 CID_154699867 | ||
| 0.238 | 0.082 | 0.238 | Superoxide dismutase inhibitor | |||
| 0.169 | 0.015 | 0.169 | GABA C receptor rho-1 antagonist | |||
| 0.183 | 0.029 | 0.183 | Cystathionine beta-synthase inhibitor | 0.095 0.083 CID_154699905 0.12 0.058 CID_154699867 | ||
| 0.159 | 0.005 | 0.159 | Peroxisome proliferator-activated receptor alpha agonist | 0.055 0.028 CID_154699867 | ||
| 0.157 | 0.004 | 0.157 | Leukotriene D4 antagonist | 0.035 0.013 CID_154699905 0.049 0.01 CID_154699867 | ||
| 0.169 | 0.017 | 0.169 | Porphobilinogen synthase inhibitor | |||
| 0.165 | 0.013 | 0.233 | Transcription factor NF kappa B stimulant | 0.216 0.008 CID_154699905 0.233 0.007 CID_154699867 | CID_154699867 | |
| 0.206 | 0.057 | 0.206 | Growth factor agonist | 0.149 0.144 CID_154699905 0.194 0.069 CID_154699867 | ||
| 0.169 | 0.022 | 0.219 | Photosensitizer | 0.186 0.016 CID_154699905 0.219 0.009 CID_154699867 | CID_154699867 | |
| 0.176 | 0.03 | 0.176 | Antibacterial (Helicobacter pylori) | 0.17 0.033 CID_154699905 0.123 0.077 CID_154699867 | ||
| 0.154 | 0.01 | 0.154 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.154 | 0.009 | 0.154 | Biliverdin reductase inhibitor | 0.062 0.039 CID_154699867 | ||
| 0.146 | 0.003 | 0.146 | ATP citrate lysase inhibitor | 0.032 0.021 CID_154699905 0.032 0.021 CID_154699867 | ||
| 0.149 | 0.008 | 0.149 | ATPase (Vacuolar H+) inhibitor | 0.146 0.009 CID_154699905 0.139 0.01 CID_154699867 | ||
| 0.15 | 0.011 | 0.15 | Argininosuccinate synthase inhibitor | 0.078 0.026 CID_154699867 | ||
| 0.155 | 0.018 | 0.155 | Electrolyte absorption antagonist | |||
| 0.141 | 0.004 | 0.141 | Sphingosine kinase inhibitor | 0.074 0.02 CID_154699905 | ||
| 0.136 | 0.001 | 0.136 | Thromboxane agonist | 0.024 0.003 CID_154699905 0.024 0.003 CID_154699867 | ||
| 0.14 | 0.005 | 0.212 | Interferon inducer | 0.212 0.003 CID_154699905 0.167 0.004 CID_154699867 | CID_154699905 | |
| 0.142 | 0.008 | 0.142 | Glycine receptor agonist | 0.094 0.025 CID_154699905 0.132 0.01 CID_154699867 | ||
| 0.143 | 0.01 | 0.143 | Ornithine carbamoyltransferase inhibitor | 0.059 0.032 CID_154699905 0.062 0.03 CID_154699867 | ||
| 0.134 | 0.005 | 0.134 | Sphingosine 1-phosphate receptor 5 agonist | |||
| 0.132 | 0.003 | 0.132 | Leukotriene C antagonist | 0.059 0.032 CID_154699905 0.068 0.016 CID_154699867 | ||
| 0.141 | 0.014 | 0.141 | Aminopeptidase I inhibitor | |||
| 0.129 | 0.003 | 0.129 | Leukotriene B4 receptor 2 antagonist | 0.061 0.004 CID_154699905 0.052 0.004 CID_154699867 | ||
| 0.144 | 0.019 | 0.144 | Thioredoxin inhibitor | 0.142 0.02 CID_154699905 0.144 0.019 CID_154699867 | ||
| 0.162 | 0.038 | 0.162 | Cathepsin H inhibitor | |||
| 0.124 | 0.001 | 0.124 | Prostaglandin F2 alpha agonist | 0.065 0.003 CID_154699905 0.063 0.003 CID_154699867 | ||
| 0.131 | 0.011 | 0.149 | Na+ K+ transporting ATPase inhibitor | 0.149 0.006 CID_154699905 0.141 0.008 CID_154699867 | CID_154699905 | |
| 0.137 | 0.021 | 0.137 | ABCA1 expression enhancer | |||
| 0.149 | 0.035 | 0.149 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.172 | 0.059 | 0.204 | Diuretic | 0.139 0.087 CID_154699905 0.204 0.043 CID_154699867 | CID_154699867 | |
| 0.124 | 0.014 | 0.124 | Antimetabolite | 0.12 0.014 CID_154699905 0.105 0.015 CID_154699867 | ||
| 0.112 | 0.002 | 0.112 | Lysophosphatidic acid receptor 1 agonist | 0.029 0.012 CID_154699905 0.028 0.013 CID_154699867 | ||
| 0.118 | 0.01 | 0.118 | Peroxisome proliferator-activated receptor gamma antagonist | 0.071 0.05 CID_154699867 | ||
| 0.124 | 0.017 | 0.124 | Phenylalanine 4-hydroxylase inhibitor | |||
| 0.154 | 0.048 | 0.154 | Farnesoid X receptor antagonist | |||
| 0.122 | 0.017 | 0.154 | Glycine receptor antagonist | 0.153 0.007 CID_154699905 0.154 0.007 CID_154699867 | CID_154699867 | |
| 0.121 | 0.016 | 0.121 | Ribonucleoside-diphosphate reductase inhibitor | |||
| 0.108 | 0.003 | 0.108 | Membrane dipeptidase inhibitor | |||
| 0.19 | 0.086 | 0.19 | Psychostimulant | 0.143 0.123 CID_154699867 | ||
| 0.127 | 0.025 | 0.25 | NADH dehydrogenase inhibitor | 0.25 0.008 CID_154699905 0.246 0.008 CID_154699867 | CID_154699905 | |
| 0.118 | 0.017 | 0.118 | Ribonucleotide reductase inhibitor | |||
| 0.108 | 0.008 | 0.108 | Glutamate (mGluR6) antagonist | |||
| 0.16 | 0.061 | 0.16 | Thiol protease inhibitor | |||
| 0.105 | 0.006 | 0.11 | Nitric oxide donor | 0.11 0.005 CID_154699905 0.096 0.011 CID_154699867 | CID_154699905 | |
| 0.101 | 0.002 | 0.101 | HMG CoA reductase inhibitor | 0.078 0.004 CID_154699905 0.052 0.007 CID_154699867 | ||
| 0.109 | 0.01 | 0.109 | Phospholipase D inhibitor | |||
| 0.101 | 0.003 | 0.101 | Kainate receptor agonist | 0.043 0.025 CID_154699905 0.049 0.015 CID_154699867 | ||
| 0.146 | 0.048 | 0.146 | Adenylate cyclase inhibitor | |||
| 0.098 | 0.001 | 0.098 | Thromboxane A2 agonist | 0.019 0.006 CID_154699905 0.02 0.006 CID_154699867 | ||
| 0.115 | 0.018 | 0.124 | GABA aminotransferase inhibitor | 0.094 0.032 CID_154699905 0.124 0.014 CID_154699867 | CID_154699867 | |
| 0.099 | 0.003 | 0.099 | Leukotriene C4 antagonist | 0.037 0.032 CID_154699905 0.045 0.015 CID_154699867 | ||
| 0.126 | 0.031 | 0.126 | Alcohol dehydrogenase inhibitor | 0.081 0.079 CID_154699905 0.094 0.059 CID_154699867 | ||
| 0.098 | 0.005 | 0.098 | Vanilloid 2 antagonist | 0.052 0.036 CID_154699905 0.052 0.038 CID_154699867 | ||
| 0.093 | 0.001 | 0.093 | Lysophosphatidic acid receptor 3 agonist | 0.023 0.004 CID_154699905 0.018 0.006 CID_154699867 | ||
| 0.093 | 0.004 | 0.093 | Sphingosine kinase 1 inhibitor | |||
| 0.108 | 0.02 | 0.108 | Amidase inhibitor | |||
| 0.194 | 0.107 | 0.367 | Peptidyltransferase inhibitor | 0.365 0.01 CID_154699905 0.367 0.01 CID_154699867 | CID_154699867 | |
| 0.142 | 0.055 | 0.263 | Cyclooxygenase 3 inhibitor | 0.263 0.008 CID_154699905 0.236 0.01 CID_154699867 | CID_154699905 | |
| 0.108 | 0.023 | 0.117 | Lipase inhibitor | 0.117 0.019 CID_154699905 0.083 0.04 CID_154699867 | CID_154699905 | |
| 0.188 | 0.103 | 0.287 | Cyclic AMP phosphodiesterase inhibitor | 0.287 0.047 CID_154699905 0.221 0.079 CID_154699867 | CID_154699905 | |
| 0.09 | 0.007 | 0.202 | Mannosidase inhibitor | 0.189 0.003 CID_154699905 0.202 0.003 CID_154699867 | CID_154699867 | |
| 0.155 | 0.073 | 0.195 | Hexokinase inhibitor | 0.195 0.038 CID_154699905 0.178 0.051 CID_154699867 | CID_154699905 | |
| 0.087 | 0.005 | 0.087 | Prostaglandin EP1 antagonist | |||
| 0.099 | 0.017 | 0.099 | GABA B receptor agonist | |||
| 0.088 | 0.007 | 0.105 | Squalene synthetase inhibitor | 0.105 0.006 CID_154699905 0.092 0.007 CID_154699867 | CID_154699905 | |
| 0.087 | 0.008 | 0.087 | Adenosine deaminase inhibitor | 0.078 0.01 CID_154699905 0.075 0.011 CID_154699867 | ||
| 0.114 | 0.035 | 0.114 | Interleukin 12 antagonist | 0.102 0.05 CID_154699905 0.11 0.04 CID_154699867 | ||
| 0.089 | 0.011 | 0.089 | Sphingosine kinase 2 inhibitor | |||
| 0.084 | 0.007 | 0.084 | Retinoid X receptor agonist | |||
| 0.081 | 0.004 | 0.081 | Vanilloid 3 antagonist | |||
| 0.095 | 0.018 | 0.095 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.06 0.04 CID_154699905 0.077 0.026 CID_154699867 | ||
| 0.159 | 0.082 | 0.159 | Neurotensin receptor agonist | |||
| 0.09 | 0.015 | 0.09 | Exportin-1 inhibitor | |||
| 0.122 | 0.047 | 0.424 | AMP-activated protein kinase stimulant | 0.316 0.005 CID_154699905 0.424 0.004 CID_154699867 | CID_154699867 | |
| 0.081 | 0.007 | 0.081 | Peroxisome proliferator-activated receptor delta agonist | |||
| 0.079 | 0.006 | 0.079 | Sphingosine 1-phosphate receptor 1 agonist | |||
| 0.09 | 0.017 | 0.09 | Acetyl-CoA transferase inhibitor | 0.052 0.038 CID_154699905 | ||
| 0.081 | 0.007 | 0.081 | Retinoid X alpha receptor agonist | |||
| 0.125 | 0.053 | 0.125 | Caspase 3 inhibitor | |||
| 0.088 | 0.017 | 0.088 | Transcription factor AP-1 inhibitor | 0.078 0.023 CID_154699905 0.08 0.021 CID_154699867 | ||
| 0.08 | 0.009 | 0.08 | Sphingosine 1-phosphate receptor agonist | |||
| 0.138 | 0.067 | 0.138 | Interleukin 1 antagonist | |||
| 0.09 | 0.019 | 0.125 | Neuraminidase inhibitor | 0.118 0.01 CID_154699905 0.125 0.009 CID_154699867 | CID_154699867 | |
| 0.116 | 0.046 | 0.347 | UDP-glucose 4-epimerase inhibitor | 0.347 0.008 CID_154699905 0.225 0.015 CID_154699867 | CID_154699905 | |
| 0.106 | 0.037 | 0.106 | Bile acid receptor antagonist | |||
| 0.083 | 0.015 | 0.083 | Sphingosine 1-phosphate receptor 3 antagonist | |||
| 0.109 | 0.042 | 0.109 | Calcium antagonist | |||
| 0.113 | 0.047 | 0.113 | Creatine kinase inhibitor | |||
| 0.106 | 0.041 | 0.132 | Phosphodiesterase 6D inhibitor | 0.132 0.016 CID_154699905 0.127 0.019 CID_154699867 | CID_154699905 | |
| 0.08 | 0.017 | 0.08 | Glycine transporter 2 inhibitor | |||
| 0.076 | 0.013 | 0.125 | Alpha-mannosidase inhibitor | 0.125 0.004 CID_154699905 0.122 0.005 CID_154699867 | CID_154699905 | |
| 0.17 | 0.108 | 0.17 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.06 | 0.002 | 0.063 | Vitamin D receptor agonist | 0.063 0.002 CID_154699905 0.046 0.003 CID_154699867 | CID_154699905 | |
| 0.059 | 0.003 | 0.059 | Calcium-independent phospholipase A2 inhibitor | 0.041 0.009 CID_154699905 0.041 0.009 CID_154699867 | ||
| 0.072 | 0.017 | 0.072 | Sphingosine 1-phosphate receptor 1 antagonist | |||
| 0.059 | 0.006 | 0.059 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | |||
| 0.068 | 0.016 | 0.068 | Pregnane X receptor antagonist | |||
| 0.183 | 0.131 | 0.343 | DNA damaging | 0.343 0.043 CID_154699905 0.211 0.107 CID_154699867 | CID_154699905 | |
| 0.08 | 0.028 | 0.08 | CDC25B inhibitor | |||
| 0.084 | 0.032 | 0.084 | Elastase 1 inhibitor | |||
| 0.109 | 0.058 | 0.109 | Protease inhibitor | |||
| 0.058 | 0.007 | 0.058 | Retinoid X receptor antagonist | |||
| 0.054 | 0.004 | 0.054 | Lysophosphatidic acid 1 receptor antagonist | |||
| 0.077 | 0.028 | 0.143 | Neuraminidase (influenza) inhibitor | 0.131 0.01 CID_154699905 0.143 0.008 CID_154699867 | CID_154699867 | |
| 0.087 | 0.038 | 0.087 | Histidine decarboxylase inhibitor | |||
| 0.117 | 0.069 | 0.117 | Anesthetic local | |||
| 0.092 | 0.045 | 0.092 | Glutathione S-transferase inhibitor | |||
| 0.086 | 0.04 | 0.086 | Cathepsin G inhibitor | |||
| 0.056 | 0.012 | 0.077 | Arginase inhibitor | 0.059 0.011 CID_154699905 0.077 0.006 CID_154699867 | CID_154699867 | |
| 0.064 | 0.022 | 0.115 | Adenine nucleotide translocase inhibitor | 0.115 0.004 CID_154699905 0.115 0.004 CID_154699867 | CID_154699867 | |
| 0.069 | 0.027 | 0.069 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.067 0.028 CID_154699905 0.064 0.031 CID_154699867 | ||
| 0.108 | 0.067 | 0.108 | Interleukin 2 antagonist | |||
| 0.077 | 0.036 | 0.077 | Glucagon-like peptide 1 agonist | |||
| 0.224 | 0.183 | 0.255 | Antiobesity | 0.255 0.152 CID_154699867 | CID_154699867 | |
| 0.045 | 0.004 | 0.045 | Prostaglandin H2 antagonist | |||
| 0.065 | 0.025 | 0.065 | Glucosylceramidase inhibitor | 0.064 0.027 CID_154699905 0.056 0.036 CID_154699867 | ||
| 0.043 | 0.003 | 0.043 | Carbonic anhydrase X inhibitor | |||
| 0.043 | 0.003 | 0.043 | Carbonic anhydrase VIII inhibitor | |||
| 0.047 | 0.008 | 0.047 | Retinoid X alpha receptor antagonist | |||
| 0.093 | 0.054 | 0.099 | Glutamate release inhibitor | 0.087 0.07 CID_154699905 0.099 0.044 CID_154699867 | CID_154699867 | |
| 0.046 | 0.008 | 0.046 | Methionyl aminopeptidase 1 inhibitor | |||
| 0.05 | 0.012 | 0.05 | Glutamate (mGluR8) agonist | |||
| 0.065 | 0.027 | 0.082 | Lipocortins synthesis agonist | 0.082 0.013 CID_154699905 0.076 0.016 CID_154699867 | CID_154699905 | |
| 0.046 | 0.008 | 0.046 | Lysine carboxypeptidase inhibitor | |||
| 0.188 | 0.151 | 0.188 | Transcription factor STAT3 inhibitor | |||
| 0.052 | 0.015 | 0.052 | Sphingosine 1-phosphate receptor 3 agonist | |||
| 0.055 | 0.018 | 0.069 | Neuraminidase (Influenza A) inhibitor | 0.069 0.008 CID_154699905 0.064 0.01 CID_154699867 | CID_154699905 | |
| 0.056 | 0.019 | 0.067 | Microtubule stabilization | 0.067 0.008 CID_154699905 0.061 0.014 CID_154699867 | CID_154699905 | |
| 0.064 | 0.028 | 0.144 | Protein 50S ribosomal subunit inhibitor | 0.14 0.007 CID_154699905 0.144 0.007 CID_154699867 | CID_154699867 | |
| 0.037 | 0.004 | 0.037 | Calcium-dependent phospholipase A2 inhibitor | |||
| 0.038 | 0.004 | 0.038 | G-protein-coupled receptor 120 agonist | |||
| 0.049 | 0.015 | 0.049 | Nicotinic acid receptor agonist | |||
| 0.05 | 0.017 | 0.05 | Acetyl-CoA transferase 1 inhibitor | |||
| 0.079 | 0.047 | 0.079 | Sphingosine 1-phosphate receptor antagonist | |||
| 0.04 | 0.008 | 0.04 | Prostaglandin D2 antagonist | |||
| 0.037 | 0.006 | 0.056 | Toll-Like receptor 4 agonist | 0.056 0.003 CID_154699905 0.056 0.003 CID_154699867 | CID_154699867 | |
| 0.06 | 0.03 | 0.06 | Angiotensin-converting enzyme inhibitor | |||
| 0.036 | 0.005 | 0.037 | 1,3-Beta-glucan synthase inhibitor | 0.037 0.005 CID_154699905 0.035 0.006 CID_154699867 | CID_154699905 | |
| 0.097 | 0.067 | 0.097 | Bronchodilator | |||
| 0.036 | 0.006 | 0.036 | Retinoid X gamma receptor antagonist | |||
| 0.039 | 0.009 | 0.039 | Elastase 3A inhibitor | |||
| 0.039 | 0.009 | 0.039 | Elastase 3B inhibitor | |||
| 0.039 | 0.009 | 0.039 | Elastase 2B inhibitor | |||
| 0.047 | 0.017 | 0.047 | Kainate receptor 2 antagonist | |||
| 0.067 | 0.039 | 0.067 | NMDA receptor agonist | |||
| 0.05 | 0.022 | 0.05 | Geranyltranstransferase inhibitor | |||
| 0.06 | 0.032 | 0.06 | Acetyl-CoA transferase 2 inhibitor | |||
| 0.055 | 0.027 | 0.055 | Plasminogen activator inhibitor antagonist | |||
| 0.055 | 0.028 | 0.055 | Bombesin 2 receptor antagonist | |||
| 0.046 | 0.018 | 0.046 | Retinoic acid alpha receptor agonist | |||
| 0.065 | 0.038 | 0.065 | Caspase 9 inhibitor | |||
| 0.095 | 0.068 | 0.095 | Carbonic anhydrase III inhibitor | |||
| 0.031 | 0.004 | 0.031 | Retinoid X beta receptor antagonist | |||
| 0.03 | 0.005 | 0.03 | Isoleucine-tRNA ligase inhibitor | 0.027 0.008 CID_154699905 0.024 0.012 CID_154699867 | ||
| 0.046 | 0.02 | 0.046 | G protein-coupled receptor agonist | |||
| 0.181 | 0.157 | 0.181 | Neuropeptide Y2 antagonist | |||
| 0.041 | 0.016 | 0.041 | Glutamate (mGluR8) antagonist | |||
| 0.042 | 0.018 | 0.042 | Phosphoglycerate kinase inhibitor | |||
| 0.033 | 0.009 | 0.033 | Retinoid X gamma receptor agonist | |||
| 0.028 | 0.005 | 0.028 | Neuraminidase (Influenza B) inhibitor | |||
| 0.063 | 0.04 | 0.063 | HIV-1 integrase (Strand Transfer) inhibitor | |||
| 0.037 | 0.015 | 0.037 | Cholesterol ester transfer protein antagonist | |||
| 0.065 | 0.043 | 0.065 | HIV-1 integrase (3'-Processing) inhibitor | |||
| 0.033 | 0.011 | 0.033 | Peroxisome proliferator-activated receptor alpha antagonist | |||
| 0.031 | 0.009 | 0.031 | Retinoic acid receptor agonist | |||
| 0.035 | 0.016 | 0.035 | Plasmepsin I inhibitor | |||
| 0.061 | 0.042 | 0.061 | Purinergic P2X1 antagonist | |||
| 0.049 | 0.031 | 0.049 | Cholesterol esterase inhibitor | |||
| 0.039 | 0.02 | 0.039 | Calcitonin receptor agonist | |||
| 0.027 | 0.009 | 0.027 | Retinoic acid gamma receptor agonist | |||
| 0.061 | 0.044 | 0.061 | Cannabinoid CB1 receptor antagonist | |||
| 0.028 | 0.011 | 0.028 | Kainate receptor 1 antagonist | |||
| 0.022 | 0.005 | 0.022 | Methylmalonyl-CoA mutase inhibitor | |||
| 0.063 | 0.047 | 0.063 | Beta 3 adrenoreceptor antagonist | |||
| 0.028 | 0.012 | 0.039 | Vanilloid 2 agonist | 0.039 0.004 CID_154699905 0.039 0.004 CID_154699867 | CID_154699867 | |
| 0.089 | 0.073 | 0.154 | Xanthine oxidase inhibitor | 0.149 0.035 CID_154699905 0.154 0.033 CID_154699867 | CID_154699867 | |
| 0.097 | 0.081 | 0.097 | Nav1.4 sodium channel blocker | |||
| 0.028 | 0.013 | 0.028 | Purinergic P2Y12 antagonist | 0.02 0.018 CID_154699867 | ||
| 0.132 | 0.117 | 0.132 | Dual specificity phosphatase inhibitor | |||
| 0.049 | 0.034 | 0.049 | HCV NS3/NS4A protease inhibitor | |||
| 0.034 | 0.019 | 0.034 | Glutamate (mGluR3) agonist | |||
| 0.025 | 0.011 | 0.025 | Retinoid X beta receptor agonist | |||
| 0.034 | 0.021 | 0.034 | Carboxypeptidase B inhibitor | |||
| 0.024 | 0.011 | 0.026 | Vitamin D receptor antagonist | 0.026 0.009 CID_154699905 0.023 0.013 CID_154699867 | CID_154699905 | |
| 0.155 | 0.141 | 0.376 | Antiamyloidogenic | 0.376 0.033 CID_154699905 0.256 0.068 CID_154699867 | CID_154699905 | |
| 0.041 | 0.028 | 0.041 | Kainate receptor antagonist | |||
| 0.02 | 0.007 | 0.02 | N-Acetylated alpha-linked acidic dipeptidase inhibitor | |||
| 0.047 | 0.035 | 0.047 | GP IIb/IIIa receptor antagonist | |||
| 0.08 | 0.068 | 0.08 | Estrogen-related receptor beta agonist | |||
| 0.037 | 0.026 | 0.037 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | |||
| 0.022 | 0.011 | 0.022 | Retinoic acid beta receptor agonist | |||
| 0.049 | 0.038 | 0.049 | CD45 antagonist | |||
| 0.037 | 0.027 | 0.037 | 5-Alpha-reductase inhibitor | |||
| 0.067 | 0.058 | 0.067 | Epoxide hydrolase inhibitor | |||
| 0.081 | 0.071 | 0.081 | Interleukin 5 antagonist | |||
| 0.041 | 0.032 | 0.041 | Macrophage elastase inhibitor | |||
| 0.026 | 0.019 | 0.026 | Urotensin II agonist | |||
| 0.019 | 0.012 | 0.019 | Aminopeptidase A inhibitor | |||
| 0.019 | 0.013 | 0.019 | Retinoic acid receptor antagonist | |||
| 0.017 | 0.011 | 0.028 | Ileal bile acid transport inhibitor | 0.019 0.01 CID_154699905 0.028 0.005 CID_154699867 | CID_154699867 | |
| 0.028 | 0.022 | 0.028 | Glucagon receptor antagonist | |||
| 0.012 | 0.007 | 0.012 | Calcineurin inhibitor | |||
| 0.068 | 0.063 | 0.068 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.012 | 0.007 | 0.012 | Immunosuppressant Cyclosporine-like | |||
| 0.013 | 0.009 | 0.013 | Carbonic anhydrase XI inhibitor | |||
| 0.017 | 0.013 | 0.017 | Free fatty acid receptor 1 agonist | |||
| 0.036 | 0.033 | 0.036 | GABA uptake inhibitor | |||
| 0.046 | 0.042 | 0.074 | Cytokine production stimulant | 0.074 0.006 CID_154699905 0.063 0.01 CID_154699867 | CID_154699905 | |
| 0.034 | 0.031 | 0.034 | Cholecystokinin B agonist | |||
| 0.063 | 0.061 | 0.063 | MDM2 inhibitor | |||
| 0.046 | 0.044 | 0.046 | Squalene epoxidase inhibitor | |||
| 0.011 | 0.01 | 0.011 | Glutamate (mGluR6) agonist | |||
| 0.026 | 0.025 | 0.026 | Hedgehog signaling activator | |||
| 0.039 | 0.038 | 0.039 | Purinergic P2Y antagonist | |||
| 0.04 | 0.039 | 0.04 | AICAR transformylase inhibitor | |||
| 0.089 | 0.094 | 0.092 | Chelator | 0.092 0.09 CID_154699867 | CID_154699867 | |
| 0.014 | 0.02 | 0.019 | Telomerase stimulant | 0.019 0.009 CID_154699905 0.019 0.009 CID_154699867 | CID_154699867 | |
| 0.047 | 0.054 | 0.129 | Heparanase inhibitor | 0.087 0.005 CID_154699905 0.129 0.003 CID_154699867 | CID_154699867 | |
| 0.005 | 0.023 | 0.019 | Antibiotic Macrolide-like | 0.019 0.007 CID_154699905 0.017 0.008 CID_154699867 | CID_154699905 | |
| 0.108 | 0.129 | 0.254 | Anticoagulant | 0.214 0.048 CID_154699905 0.254 0.038 CID_154699867 | CID_154699867 | |
| 0.074 | 0.098 | 0.128 | Uric acid excretion stimulant | 0.094 0.059 CID_154699905 0.128 0.033 CID_154699867 | CID_154699867 | |
| 0.012 | 0.042 | 0.024 | Corticosteroid-like | 0.024 0.011 CID_154699905 0.022 0.014 CID_154699867 | CID_154699905 | |
| 0.013 | 0.049 | 0.025 | Antibiotic Anthracycline-like | 0.024 0.006 CID_154699905 0.025 0.005 CID_154699867 | CID_154699867 | |
| 0.025 | 0.068 | 0.074 | Antibiotic Aminoglycoside-like | 0.071 0.006 CID_154699905 0.074 0.005 CID_154699867 | CID_154699867 | |
| 0.047 | 0.106 | 0.167 | Topoisomerase II alpha inhibitor | 0.167 0.02 CID_154699905 0.135 0.026 CID_154699867 | CID_154699905 | |
| 0.026 | 0.087 | 0.06 | Carbonic anhydrase XIV inhibitor | 0.06 0.025 CID_154699905 0.058 0.026 CID_154699867 | CID_154699905 | |
| 0.044 | 0.116 | 0.099 | Histone deacetylase stimulant | 0.099 0.029 CID_154699905 0.077 0.047 CID_154699867 | CID_154699905 | |
| 0.044 | 0.116 | 0.099 | Histone deacetylase SIRT1 stimulant | 0.099 0.029 CID_154699905 0.077 0.047 CID_154699867 | CID_154699905 | |
| 0.07 | 0.144 | 0.161 | Beta amyloid protein antagonist | 0.161 0.033 CID_154699905 | CID_154699905 | |
| 0.021 | 0.105 | 0.052 | Aldose reductase inhibitor | 0.052 0.038 CID_154699867 | CID_154699867 | |
| 0.058 | 0.147 | 0.219 | Topoisomerase II inhibitor | 0.219 0.029 CID_154699905 0.205 0.032 CID_154699867 | CID_154699905 | |
| 0.017 | 0.12 | 0.051 | Phosphorylase inhibitor | 0.051 0.03 CID_154699867 | CID_154699867 | |
| 0.008 | 0.13 | 0.038 | Sodium/glucose cotransporter 2 inhibitor | 0.032 0.011 CID_154699905 0.038 0.009 CID_154699867 | CID_154699867 | |
| 0.085 | 0.213 | 0.267 | NOS3 expression enhancer | 0.267 0.023 CID_154699905 0.256 0.025 CID_154699867 | CID_154699905 | |
| 0.027 | 0.161 | 0.085 | Glucose-6-phosphate translocase inhibitor | 0.085 0.009 CID_154699905 0.073 0.014 CID_154699867 | CID_154699905 | |
| 0.01 | 0.144 | 0.034 | Sodium/glucose cotransporter inhibitor | 0.03 0.011 CID_154699905 0.034 0.009 CID_154699867 | CID_154699867 | |
| 0.009 | 0.174 | 0.049 | Protein 30S ribosomal subunit inhibitor | 0.049 0.008 CID_154699905 0.049 0.008 CID_154699867 | CID_154699867 | |
| 0.026 | 0.271 | 0.237 | Topoisomerase I inhibitor | 0.237 0.019 CID_154699905 0.182 0.031 CID_154699867 | CID_154699905 | |
| 0.056 | 0.398 | 0.124 | DNA repair enzyme inhibitor | 0.124 0.065 CID_154699905 0.115 0.082 CID_154699867 | CID_154699905 | |
| 0.027 | 0.392 | 0.11 | Beta glucuronidase inhibitor | 0.11 0.057 CID_154699905 0.093 0.081 CID_154699867 | CID_154699905 | |
| 0.018 | 0.557 | 0.122 | Multidrug resistance-associated protein 1 inhibitor | 0.122 0.046 CID_154699905 | CID_154699905 | |
| 0.029 | 0.627 | 0.227 | Angiogenesis inhibitor | 0.227 0.141 CID_154699867 | CID_154699867 | |
| 0.046 | 0.931 | 0.13 | CC chemokine 6 receptor antagonist | 0.13 0.07 CID_154699905 0.124 0.098 CID_154699867 | CID_154699905 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |